惠升医药健康6个月持有期混合(010405)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
1,170,540,000 |
1,128,790,000 |
1,003,680 |
42,755,100 |
-41,751,420 |
-3.57% |
2023/12/31 |
1,392,920,000 |
1,170,540,000 |
5,885,060 |
228,263,000 |
-222,377,940 |
-15.96% |
2023/12/31 |
1,221,640,000 |
1,170,540,000 |
1,289,490 |
52,392,800 |
-51,103,310 |
-4.18% |
2023/9/30 |
1,304,850,000 |
1,221,640,000 |
1,033,440 |
84,237,100 |
-83,203,660 |
-6.38% |
2023/6/30 |
1,392,920,000 |
1,304,850,000 |
3,562,130 |
91,633,100 |
-88,070,970 |
-6.32% |
2023/6/30 |
1,358,150,000 |
1,304,850,000 |
2,336,970 |
55,641,300 |
-53,304,330 |
-3.92% |
2023/3/31 |
1,392,920,000 |
1,358,150,000 |
1,225,160 |
35,991,800 |
-34,766,640 |
-2.5% |
2022/12/31 |
1,717,360,000 |
1,392,920,000 |
46,062,500 |
370,500,000 |
-324,437,500 |
-18.89% |
2022/12/31 |
1,389,570,000 |
1,392,920,000 |
31,785,500 |
28,439,600 |
3,345,900 |
0.24% |
2022/9/30 |
1,419,290,000 |
1,389,570,000 |
3,163,470 |
32,875,900 |
-29,712,430 |
-2.09% |
2022/6/30 |
1,717,360,000 |
1,419,290,000 |
11,113,600 |
309,184,000 |
-298,070,400 |
-17.36% |
2022/6/30 |
1,654,810,000 |
1,419,290,000 |
2,104,360 |
237,625,000 |
-235,520,640 |
-14.23% |
2022/3/31 |
1,717,360,000 |
1,654,810,000 |
9,009,220 |
71,559,000 |
-62,549,780 |
-3.64% |
2021/12/31 |
2,210,770,000 |
1,717,360,000 |
252,182,000 |
745,598,000 |
-493,416,000 |
-22.32% |
2021/12/31 |
1,772,160,000 |
1,717,360,000 |
11,057,200 |
65,858,900 |
-54,801,700 |
-3.09% |
2021/9/30 |
2,020,410,000 |
1,772,160,000 |
11,492,600 |
259,740,000 |
-248,247,400 |
-12.29% |
2021/6/30 |
2,210,770,000 |
2,020,410,000 |
229,632,000 |
419,999,000 |
-190,367,000 |
-8.61% |
2021/6/30 |
2,241,920,000 |
2,020,410,000 |
198,484,000 |
419,999,000 |
-221,515,000 |
-9.88% |
2021/3/31 |
2,210,770,000 |
2,241,920,000 |
31,147,800 |
0 |
31,147,800 |
1.41% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。